News and Updates

Mabwell secures NMPA approval for a novel LILRB4/CD3 bispecific T-cell engager, marking a breakthrough in the treatment of aggressive blood cancers.

Explore the hidden privacy risks in medical AI, from data re-identification to deep learning vulnerabilities, and how to protect patient data security.

Discover how the drug atrasentan is revolutionizing IgA nephropathy treatment by reducing proteinuria and protecting long-term kidney function.

Discover five essential facts about daraxonrasib, a breakthrough KRAS inhibitor offering new hope for treating aggressive pancreatic cancer.

Explore new anthropometric research on facial index variations among medical students and its significance for clinical anatomy and forensic medicine.

HHS is proposing strict new clinical trial reforms to protect U.S. biotech innovation and stop the Chinese sector from accessing sensitive medical data.

Discover how Operation Trailblazer aims to revitalize U.S. clinical trials, improve patient enrollment, and accelerate life-saving medical innovation.

A new clinical trial is underway to test two experimental drugs against a fast-growing Ebola outbreak, aiming to improve patient survival rates globally.

A breakthrough study on a new GLP-1 drug reveals significant, sustainable weight loss results, offering a promising future for obesity and metabolic care.

The HHS is fast-tracking early-stage drug research to boost domestic innovation and counter global competition. Learn how this shift impacts biotech.